Event Type
Disclosure
Voluntary
Variant
8-K
Other Events . On January 7, 2026, Genprex, Inc. (the “Company”) was formally notified (the “Compliance Notice”) that the Nasdaq Hearings Panel (the “Panel”) of
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIG